Latest
06.27.2024
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
Read Article![](https://beringcapital.com/wp-content/uploads/2024/07/GettyImages-1134295967-aspect-ratio-209-135.jpeg)
03.11.2024
Cellworks Personalized Therapy Biosimulation Study Produces Superior OS and DFS Predictions for Gastroesophageal Cancer Patients
Read Article![](https://beringcapital.com/wp-content/uploads/2024/03/giorgio-trovato-L2QpKQfe9-k-unsplash-scaled-aspect-ratio-209-135-scaled.jpg)
02.28.2024
CalciMedica Announces Presentation of a Preclinical Study of Auxora in Acute Kidney Injury at the AKI & CRRT Conference
Read Article![](https://beringcapital.com/wp-content/uploads/2024/03/shutterstock_617485316-scaled-aspect-ratio-209-135-scaled.jpg)
02.13.2024
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for Treatment of Severe Acute Kidney Injury
Read Article![](https://beringcapital.com/wp-content/uploads/2024/02/shutterstock_1853126911-copy-scaled-aspect-ratio-209-135-scaled.jpeg)
06.05.2023
Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Car
Read Article![](https://beringcapital.com/wp-content/uploads/2023/06/shutterstock_363414059-aspect-ratio-209-135.jpg)
05.18.2023
OncoResponse Awarded $13 Million in Funding from CPRIT to Advance Cancer Immunotherapy
Read Article![](https://beringcapital.com/wp-content/uploads/2023/06/national-cancer-institute-XknuBmnjbKg-unsplash-aspect-ratio-209-135.jpg)